Oncology nutrition market seen reaching $8.14 billion by 2033

Coherent Market Insights says the global oncology nutrition market will grow from $4.66 billion in 2026 to $8.14 billion by 2033, a compound annual growth rate of 8.3%. The report highlights demand across hospitals, homecare and specialty clinics, with oral supplements, enteral nutrition and parenteral nutrition among the key product segments.

Why it matters: - Oncology nutrition is becoming a bigger part of cancer care as demand rises for products that address malnutrition, cachexia, immune support and digestive health. - The market’s projected growth from 2026 to 2033 points to expanding commercial opportunities for nutrition companies, suppliers and healthcare providers.

What happened: - Coherent Market Insights released a forecast report on the global oncology nutrition market covering 2026-2033. - The market is estimated at USD 4.66 billion in 2026 and projected to reach USD 8.14 billion by 2033. - The forecast implies an 8.3% compound annual growth rate over the period. - The report was published June 8, 2026, from Burlingame, California. - The company is offering a sample copy of the report.

The details: - The report includes global and country-level forecasts, competitive landscape analysis and supply chain evaluation. - The study examines market dynamics, investment opportunities, technological advancements, financial performance and future growth trends. - The analysis uses SWOT review and includes growth drivers, restraints, trends and challenges. - Market segmentation covers product type, application and end user. - Product types include oral nutrition supplements, enteral nutrition, parenteral nutrition and others. - Applications include malnutrition prevention, cachexia management, immune system support, digestive health and others. - End users include hospitals, homecare settings, specialty clinics and others. - Regional coverage spans North America, Europe, Asia-Pacific, South America, and the Middle East & Africa. - Companies named in the report include Nutricia Advanced Medical Nutrition, Abbott Laboratories, Nestlé Health Science, Fresenius Kabi, Danone Nutricia, Mead Johnson & Company, B. Braun Melsungen AG, Baxter International Inc., Pfizer Inc. and Reckitt Benckiser. - The report also highlights competitive developments such as expansions, product launches, acquisitions and collaborations. - A purchase page is available for the premium report.

Between the lines: - The report frames oncology nutrition as a category shaped by both clinical need and commercial competition. - Interest in segment-level forecasting suggests buyers are looking for clearer signals on where demand is strongest by product, use case and region. - The emphasis on competitive benchmarking, SWOT analysis and Porter’s Five Forces points to a market where strategy and pricing power may matter as much as product innovation.

What’s next: - Coherent Market Insights says the report is meant to support strategic decision-making, investment planning and market-entry analysis. - The company says future demand will be shaped by regional consumption patterns, segment growth and broader market dynamics. - The report’s FAQ section says customization is available, but the release does not provide details on scope or pricing.